Diabetes Care, Vol 21, Issue 7 1167-1172, Copyright © 1998 by American Diabetes Association

ARTICLES

Effects of diabetes and level of glycemia on all-cause and cardiovascular mortality. The San Antonio Heart Study

M Wei, SP Gaskill, SM Haffner and MP Stern
Cooper Institute for Aerobics Research, Dallas, Texas, USA.

OBJECTIVE: Although the level of hyperglycemia is clearly a risk factor for microvascular complications in diabetic patients, its role in macrovascular complications remains controversial. We followed 4,875 subjects (65% Mexican-American) for 7-8 years to investigate the effects of diabetes and hyperglycemia on all-cause and cardiovascular disease (CVD) mortality. These end points were also analyzed according to quartiles of baseline fasting plasma glucose among diabetic participants. RESEARCH DESIGN AND METHODS: The Cox proportional hazards model was used to estimate the relative risks (RRs) for all-cause and CVD mortality. RESULTS: Diabetes was significantly associated with increased all-cause mortality (RR [95% CI] = 2.1 [1.3-3.5] in men; 3.2 [1.9-5.4] in women) and increased CVD mortality (3.2 [1.4-7.1] in men; 8.5 [2.8-25.2] in women). Among diabetic subjects, those in quartile 4 had a 4.2-fold greater risk of all-cause mortality (P < 0.001) and a 4.7-fold greater risk of CVD mortality (P = 0.01) than those in quartiles 1 and 2 combined. After further adjustment for other potential risk factors, subjects in quartile 4 had a 4.9-fold greater risk of all-cause mortality and a 4.9-fold greater risk of CVD mortality than those in quartiles 1 and 2. In addition, hypertension, current smoking, and cholesterol > 6.2 mmol/l were significant predictors of CVD mortality using Cox models. CONCLUSIONS: We conclude that diabetes is a predictor of both all-cause and CVD mortality in the general population and that both hyperglycemia and common CVD risk factors are important predictors of all-cause and CVD mortality in diabetic subjects.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				S. Kidambi and S. B. Patel Diabetes Mellitus: Considerations for Dentistry J Am Dent Assoc, October 1, 2008; 139(suppl_5): 8S - 18S. [Abstract] [Full Text] [PDF]

				C. Bianchi, R. Miccoli, G. Penno, and S. Del Prato Primary Prevention of Cardiovascular Disease in People With Dysglycemia Diabetes Care, February 1, 2008; 31(Supplement_2): S208 - S214. [Abstract] [Full Text] [PDF]

				A. Shankar, R. Klein, B. E. K. Klein, and S. E. Moss Association between Glycosylated Hemoglobin Level and Cardiovascular and All-Cause Mortality in Type 1 Diabetes Am. J. Epidemiol., August 15, 2007; 166(4): 393 - 402. [Abstract] [Full Text] [PDF]

				E. L.M. Barr, P. Z. Zimmet, T. A. Welborn, D. Jolley, D. J. Magliano, D. W. Dunstan, A. J. Cameron, T. Dwyer, H. R. Taylor, A. M. Tonkin, et al. Risk of Cardiovascular and All-Cause Mortality in Individuals With Diabetes Mellitus, Impaired Fasting Glucose, and Impaired Glucose Tolerance: The Australian Diabetes, Obesity, and Lifestyle Study (AusDiab) Circulation, July 10, 2007; 116(2): 151 - 157. [Abstract] [Full Text] [PDF]

				S D West, D J Nicoll, and J R Stradling Prevalence of obstructive sleep apnoea in men with type 2 diabetes Thorax, November 1, 2006; 61(11): 945 - 950. [Abstract] [Full Text] [PDF]

				A. Handberg, K. Levin, K. Hojlund, and H. Beck-Nielsen Identification of the Oxidized Low-Density Lipoprotein Scavenger Receptor CD36 in Plasma: A Novel Marker of Insulin Resistance Circulation, September 12, 2006; 114(11): 1169 - 1176. [Abstract] [Full Text] [PDF]

				N. L. Smith, J. I. Barzilay, R. Kronmal, T. Lumley, D. Enquobahrie, and B. M. Psaty New-onset diabetes and risk of all-cause and cardiovascular mortality: the cardiovascular health study. Diabetes Care, September 1, 2006; 29(9): 2012 - 2017. [Abstract] [Full Text] [PDF]

				Authors/Task Force Members, K. Fox, M. A. A. Garcia, D. Ardissino, P. Buszman, P. G. Camici, F. Crea, C. Daly, G. De Backer, P. Hjemdahl, et al. Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology Eur. Heart J., June 1, 2006; 27(11): 1341 - 1381. [Full Text] [PDF]

				S. M. Haffner Abdominal obesity, insulin resistance, and cardiovascular risk in pre-diabetes and type 2 diabetes Eur. Heart J. Suppl., May 1, 2006; 8(suppl_B): B20 - B25. [Abstract] [Full Text] [PDF]

				A. R. Gosmanov, F. B. Stentz, and A. E. Kitabchi De novo emergence of insulin-stimulated glucose uptake in human aortic endothelial cells incubated with high glucose Am J Physiol Endocrinol Metab, March 1, 2006; 290(3): E516 - E522. [Abstract] [Full Text] [PDF]

				D. Manzella, R. Grella, A. M. Abbatecola, and G. Paolisso Repaglinide Administration Improves Brachial Reactivity in Type 2 Diabetic Patients Diabetes Care, February 1, 2005; 28(2): 366 - 371. [Abstract] [Full Text] [PDF]

				A. Juutilainen, S. Kortelainen, S. Lehto, T. Ronnemaa, K. Pyorala, and M. Laakso Gender Difference in the Impact of Type 2 Diabetes on Coronary Heart Disease Risk Diabetes Care, December 1, 2004; 27(12): 2898 - 2904. [Abstract] [Full Text] [PDF]

				E. B. Levitan, Y. Song, E. S. Ford, and S. Liu Is Nondiabetic Hyperglycemia a Risk Factor for Cardiovascular Disease?: A Meta-analysis of Prospective Studies Arch Intern Med, October 25, 2004; 164(19): 2147 - 2155. [Abstract] [Full Text] [PDF]

				C.-H. Tseng Mortality and Causes of Death in a National Sample of Diabetic Patients in Taiwan Diabetes Care, July 1, 2004; 27(7): 1605 - 1609. [Abstract] [Full Text] [PDF]

				G. F. Salles, K. V. Bloch, and C. R.L. Cardoso Mortality and Predictors of Mortality in a Cohort of Brazilian Type 2 Diabetic Patients Diabetes Care, June 1, 2004; 27(6): 1299 - 1305. [Abstract] [Full Text] [PDF]

				E. Barrett-Connor, E.-G. V. Giardina, A. K. Gitt, U. Gudat, H. O. Steinberg, and D. Tschoepe Women and Heart Disease: The Role of Diabetes and Hyperglycemia Arch Intern Med, May 10, 2004; 164(9): 934 - 942. [Abstract] [Full Text] [PDF]

				S. H. Saydah, J. Fradkin, and C. C. Cowie Poor Control of Risk Factors for Vascular Disease Among Adults With Previously Diagnosed Diabetes JAMA, January 21, 2004; 291(3): 335 - 342. [Abstract] [Full Text] [PDF]

				Prevention or Delay of Type 2 Diabetes Diabetes Care, January 1, 2004; 27(90001): s47 - 47. [Full Text] [PDF]

				R. T. Hurst and R. W. Lee Increased Incidence of Coronary Atherosclerosis in Type 2 Diabetes Mellitus: Mechanisms and Management Ann Intern Med, November 18, 2003; 139(10): 824 - 834. [Abstract] [Full Text] [PDF]

				S. Ma, J. Cutter, C. E. Tan, S. K. Chew, and E. S. Tai Associations of Diabetes Mellitus and Ethnicity with Mortality in a Multiethnic Asian Population: Data from the 1992 Singapore National Health Survey Am. J. Epidemiol., September 15, 2003; 158(6): 543 - 552. [Abstract] [Full Text] [PDF]

				N. Satoh, Y. Ogawa, T. Usui, T. Tagami, S. Kono, H. Uesugi, H. Sugiyama, A. Sugawara, K. Yamada, A. Shimatsu, et al. Antiatherogenic Effect of Pioglitazone in Type 2 Diabetic Patients Irrespective of the Responsiveness to Its Antidiabetic Effect Diabetes Care, September 1, 2003; 26(9): 2493 - 2499. [Abstract] [Full Text] [PDF]

				D. E. King, A. G. Mainous III, T. A. Buchanan, and W. S. Pearson C-Reactive Protein and Glycemic Control in Adults With Diabetes Diabetes Care, May 1, 2003; 26(5): 1535 - 1539. [Abstract] [Full Text] [PDF]

				The Prevention or Delay of Type 2 Diabetes Diabetes Care, January 1, 2003; 26(90001): s62 - 69. [Full Text] [PDF]

				J. R. Sowers and S. Haffner Treatment of Cardiovascular and Renal Risk Factors in the Diabetic Hypertensive Hypertension, December 1, 2002; 40(6): 781 - 788. [Full Text] [PDF]

				R. J Woodman, T. A Mori, V. Burke, I. B Puddey, G. F Watts, and L. J Beilin Effects of purified eicosapentaenoic and docosahexaenoic acids on glycemic control, blood pressure, and serum lipids in type 2 diabetic patients with treated hypertension Am. J. Clinical Nutrition, November 1, 2002; 76(5): 1007 - 1015. [Abstract] [Full Text] [PDF]

				M. P. Stern, P. Fatehi, K. Williams, and S. M. Haffner Predicting Future Cardiovascular Disease: Do we need the oral glucose tolerance test? Diabetes Care, October 1, 2002; 25(10): 1851 - 1856. [Abstract] [Full Text] [PDF]

				A. M. Kanaya, D. Grady, and E. Barrett-Connor Explaining the Sex Difference in Coronary Heart Disease Mortality Among Patients With Type 2 Diabetes Mellitus: A Meta-analysis Arch Intern Med, August 12, 2002; 162(15): 1737 - 1745. [Abstract] [Full Text] [PDF]

				The Prevention or Delay of Type 2 Diabetes Clin. Diabetes, July 1, 2002; 20(3): 109 - 116. [Full Text] [PDF]

				The Prevention or Delay of Type 2 Diabetes Diabetes Spectr, July 1, 2002; 15(3): 147 - 157. [Full Text] [PDF]

				American Diabetes Association The Prevention or Delay of Type 2 Diabetes Diabetes Care, April 1, 2002; 25(4): 742 - 749. [Full Text] [PDF]

				P. J. Little, L. Tannock, K. L. Olin, A. Chait, and T. N. Wight Proteoglycans Synthesized by Arterial Smooth Muscle Cells in the Presence of Transforming Growth Factor-{beta}1 Exhibit Increased Binding to LDLs Arterioscler. Thromb. Vasc. Biol., January 1, 2002; 22(1): 55 - 60. [Abstract] [Full Text] [PDF]

				S. H. Saydah, M. Miret, J. Sung, C. Varas, D. Gause, and F. L. Brancati Postchallenge Hyperglycemia and Mortality in a National Sample of U.S. Adults Diabetes Care, August 1, 2001; 24(8): 1397 - 1402. [Abstract] [Full Text] [PDF]

				H. C. Gerstein, J. F. E. Mann, Q. Yi, B. Zinman, S. F. Dinneen, B. Hoogwerf, J. P. Halle, J. Young, A. Rashkow, C. Joyce, et al. Albuminuria and Risk of Cardiovascular Events, Death, and Heart Failure in Diabetic and Nondiabetic Individuals JAMA, July 25, 2001; 286(4): 421 - 426. [Abstract] [Full Text] [PDF]

				T. Morioka, M. Emoto, T. Tabata, T. Shoji, H. Tahara, H. Kishimoto, E. Ishimura, and Y. Nishizawa Glycemic Control Is a Predictor of Survival for Diabetic Patients on Hemodialysis Diabetes Care, May 1, 2001; 24(5): 909 - 913. [Abstract] [Full Text]

				Y. Ousman and M. Sharma The Irrefutable Importance of Glycemic Control Clin. Diabetes, April 1, 2001; 19(2): 71 - 72. [Full Text] [PDF]

				W. T. Noonan and R. O. Banks Renal Function and Glucose Transport in Male and Female Mice with Diet-Induced Type II Diabetes Mellitus Experimental Biology and Medicine, December 1, 2000; 225(3): 221 - 230. [Abstract] [Full Text]

				I. M Stratton, A. I Adler, H A. W Neil, D. R Matthews, S. E Manley, C. A Cull, D. Hadden, R. C Turner, and R. R Holman Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study BMJ, August 12, 2000; 321(7258): 405 - 412. [Abstract] [Full Text]

				A. I Adler, I. M Stratton, H A. W Neil, J. S Yudkin, D. R Matthews, C. A Cull, A. D Wright, R. C Turner, and R. R Holman Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study BMJ, August 12, 2000; 321(7258): 412 - 419. [Abstract] [Full Text]

				T. Hammoud, J.-F. Tanguay, and M. G. Bourassa Management of coronary artery disease: therapeutic options in patients with diabetes J. Am. Coll. Cardiol., August 1, 2000; 36(2): 355 - 365. [Abstract] [Full Text] [PDF]

				M. Wei, L. W. Gibbons, T. L. Mitchell, J. B. Kampert, M. P. Stern, and S. N. Blair Low Fasting Plasma Glucose Level as a Predictor of Cardiovascular Disease and All-Cause Mortality Circulation, May 2, 2000; 101(17): 2047 - 2052. [Abstract] [Full Text] [PDF]

				R. Klein, B. E. K. Klein, S. E. Moss, and K. J. Cruickshanks Association of Ocular Disease and Mortality in a Diabetic Population Arch Ophthalmol, November 1, 1999; 117(11): 1487 - 1495. [Abstract] [Full Text] [PDF]

				Other Articles Noted Evid. Based Nurs., October 1, 1999; 2(4): 105 - 112. [Full Text]

				M. Wei, L. W. Gibbons, T. L. Mitchell, J. B. Kampert, C. D. Lee, and S. N. Blair The Association between Cardiorespiratory Fitness and Impaired Fasting Glucose and Type 2 Diabetes Mellitus in Men Ann Intern Med, January 19, 1999; 130(2): 89 - 96. [Abstract] [Full Text] [PDF]